San Antonio Express-News; San Antonio Boy Attempts Icy Stunt by Jumping on Slick... Storyful; Car ... He's now the executive chairman of Rubius Therapeutics, a biotech firm that's also working with cell therapy to develop treatments like the CAR-Ts that don't have to be as personalized. The hope…
News
- The hottest thing in cancer drug development is a takeover target again — here's what you need to ...
- Technology companies lead US stocks higher in early trading
DEAL TALK: Juno Therapeutics soared 46.5 percent after the Wall Street Journal reported that biotech drugmaker Celgene might buy it. Juno is one of several companies developing therapies that involve genetically engineering patients' blood cells to fight cancer. Shares in Juno rose $21.21 to $66…
- VelocityTX Turns to Chile to Bolster San Antonio's Startup Scene
San Antonio—Four new businesses from Chile will be opening up shop in San Antonio in late 2018, joining a program run by the emerging ... that aims to connect entrepreneurs and investors called Broota; and multiple biotech companies, such as drug developer InnoBioscience and diagnostic maker…
- Markets Right Now: Tech, health care lead stock gains
Juno Therapeutics soared 47 percent after the Wall Street Journal reported that biotech drugmaker Celgene might buy it. The Standard & Poor's 500 index rose 13 points, or 0.5 percent, to 2,790. The Dow Jones industrial average rose 173 points, or 0.7 percent, to 25,966. The Nasdaq composite…
- Tech, health care companies help lift US stocks higher
DEAL TALK: Juno Therapeutics soared 50.9 percent after the Wall Street Journal reported that biotech drugmaker Celgene might buy it. Juno is one of several companies developing therapies that involve genetically engineering patients' blood cells to fight cancer. Juno rose $23.23 to $68.83.…